Snowball logo
logo
TKDA_logo

Takeda Pharmaceutical Company Limited

€17.90-€0.10Β  (0.56%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
3,569,0064,027,4784,263,7624,581,5514,505,7204,618,935
COGS
1,106,8461,244,0721,426,6781,580,2171,571,5881,593,589
Gross Profit
2,462,1602,783,4062,837,0843,001,3342,934,1323,025,346
Operating Expenses & Income
Operating Income
460,845490,506309,901466,370464,451481,303
Total Operating Expenses
3,108,1613,536,9723,953,8614,115,1814,041,2694,137,632
R&D Expenses
526,087633,325729,924730,227675,924699,428
Selling General & Admin Expenses
886,361997,3091,053,8191,104,7661,084,2151,114,843
Earnings from Continuing Operations
Interest Expense
(122,432)(169,698)(119,535)(137,311)(148,123)(436,410)
Interest Income
23,70062,91311,29319,63816,878346,022
Income Tax Expense
72,405-----
Net Income
Net Income
230,059317,017144,067107,928(152,390)(163,436)
Supplemental
EBIT
599,506554,900172,326312,3955,768(25,457)
EBITDA
1,052,3291,209,188900,3281,073,791726,895645,135
In millions of EUR, except % and values per 1 share